Australia Non-Invasive Prenatal Testing (NIPT) Market Size and Trends
As per DPI Research’s latest published report, the Australia Non-Invasive Prenatal Testing (NIPT) market size was valued at USD 57.8 million in 2024 and is projected to hit around USD 83.3 million by 2033, growing at a CAGR of 4.1% during the forecast period 2025 to 2033.
Australia Non-Invasive Prenatal Testing (NIPT) Market Growth Drivers
The Australian NIPT market growth can be attributed to several key drivers. Firstly, rising awareness among healthcare providers and parents about the benefits of early detection of genetic abnormalities has heightened the demand for these tests. This awareness is fuelled by educational initiatives and the increasing prevalence of hereditary genetic disorders.
Secondly, technological advancements in genomic sequencing have made NIPT more accessible and affordable. As more healthcare facilities adopt these technologies, the reliability and efficiency of non-invasive testing continue to improve, encouraging more expectant parents to opt for NIPT.
Another significant factor driving the growth of the NIPT market in Australia is supportive regulatory policies. The Australian government has recognized the potential of NIPT in improving maternal and fetal health outcomes and has implemented frameworks to encourage the adoption of such innovative testing methods. This regulatory backing not only enhances public trust in NIPT but also incentivizes providers to include these services in their offerings, further fueling market expansion.
Australia Non-Invasive Prenatal Testing (NIPT) Market Synopsis
This new market report presents a comprehensive study of the entire Australia non-invasive prenatal testing market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the Australia non-invasive prenatal testing market. The report also provides up-to-date historical market size data for the period 2018–2024 and an illustrative forecast to 2032 covering key market aspects like market value and volume for non-invasive prenatal testing in Australia.
The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, NIPT test volume, revenues, and provides forecasts through 2033. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement patterns and offers a clear view of the regulatory landscape in the Australia non-invasive prenatal testing market. Key trends in terms of collaboration deals, partnerships, mergers & acquisitions, venture capital investment, distribution, and licensing agreements are analyzed in detail. The report also explores the detailed description of SWOT analysis, market drivers, and challenges of the Australian non-invasive prenatal testing market.
The report concludes with the profiles of major players in the Australia non-invasive prenatal testing market. The key market players are evaluated on various parameters such as business overview, product outlook, and key development in the non-invasive prenatal testing market in Australia.
Some of the Prominent Players in the Australia Non-Invasive Prenatal Testing (NIPT) Market
- Healius Limited
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Novacyt
- BGI Genomics
- Natera, Inc.
- Monash IVF Group
- Virtus Health
- Sonic Healthcare Limited
- Victorian Clinical Genetics Services Limited
Report Scope of the Australia Non-Invasive Prenatal Testing (NIPT) Market
Comprehensive research methodology of the Australia non-invasive prenatal testing market
Detailed and comprehensive market overview with important analyst insights
Insights into the market determinants stimulating the Australia non-invasive prenatal testing market
Analysis of the historical growth of the market size of the Australia non-invasive prenatal testing market from 2018 to 2024
Australia non-invasive prenatal testing market size estimation and forecast from 2025 to 2033 and growth rate up to 2033
A comprehensive analysis evaluates the number of NIPT tests performed in Australia with eight-year forecast
A complete assessment of market potential and opportunities for this innovation-driven Australia non-invasive prenatal testing market has been done with eight-year forecast
Thoroughly assess the overall Australia potential non-invasive prenatal testing (NIPT) volume and future trends with eight-year forecast
A detailed insight into the regulatory framework of the Australia non-invasive prenatal testing market
Features reimbursement patterns of the Australia non-invasive prenatal testing market with utmost precision
Tracks recent competitive developments, approaches, recent industry developments, mergers & acquisitions, collaboration deals, partnership deals, distribution, exclusive, and licensing agreements.
A comprehensive list of the key players along with the analysis of their current NIPT test portfolios, business overview, and recent development
Key Questions the Report Addresses
- What is the current scenario of the Australia non-invasive prenatal testing market?
- What is the total market size and forecast (until 2033) for the Australia non-invasive prenatal testing market?
- How has the potential Australia market performed so far, and how will it perform in the coming years?
- How many NIPT tests were performed in Australia during 2018–2033?
- What are the key marketed NIPT tests available in Australia?
- What are the major drivers of the Australia non-invasive prenatal testing market?
- What are the major challenges of the Australia non-invasive prenatal testing market?
- What is the reimbursement pattern in the Australia non-invasive prenatal testing market?
- What is the regulatory framework in the Australia non-invasive prenatal testing market?
- What are the major deals and agreement happenings in the non-invasive prenatal testing market?
- Who are the top Australia market players? What are their happenings, current developments, and scenarios?
- How is the Australia market predicted to develop in the future?
1. Introduction
2. Research Methodology
3. Executive Summary
4. Australia Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2033)
5. Australia Non-Invasive Prenatal Testing Market Size and Forecast (2018 – 2033)
6. Australia Non-Invasive Prenatal Testing Market Growth Drivers and Challenges
6.1 Market Growth Drivers
6.2 Market Challenges
7. Non-Invasive Prenatal Testing Comparative Analysis
8. Reimbursement Environment of the Australia Non-Invasive Prenatal Testing Market
9. Regulation Framework of the Australia Non-Invasive Prenatal Testing Market
10. Major Deals and Agreements in the Non-Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals
11. SWOT Analysis
11.1 Strengths
11.2 Weaknesses
11.3 Opportunities
11.4 Threats
12. Key Companies Analysis
12.1 Victorian Clinical Genetics Services Limited
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Recent Development
12.2 Healius Limited
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Recent Development
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Recent Development
12.5 Illumina, Inc.
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Recent Development
12.6 Novacyt
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Recent Development
12.7 BGI Genomics
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Recent Development
12.8 Natera, Inc.
12.8.1 Business Overview
12.8.2 Product Portfolio
12.8.3 Recent Development
12.9 Monash IVF Group
12.9.1 Business Overview
12.9.2 Product Portfolio
12.9.3 Recent Development
12.10 Virtus Health
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Recent Development
12.11 Sonic Healthcare Limited
12.11.1 Business Overview
12.11.2 Product Portfolio
12.11.3 Recent Development
